We finally performed the TAC surgery to these mice and found that heterozygous Atm gene deletion attenuated the progression of severe left ventricular dysfunction (Fig. 7a,b), alleviated the signs of heart failure (Fig. 7c) and improved the mortality in Xrcc1αMHC-Cre mice (Fig. 7d). The gene discussed is ATM; the disease is heart failure.